Altered myeloid development and acute leukemia in transgenic mice expressing PML-RARα under control of cathepsin G regulatory sequences

Blood

Volumn 89, Issue 2, 1997, Pages 376-387

  Grisolano, Jay L ^b   Wesselschmidt, Robin L ^b   Pelicci, Pier Giuseppe ^b   Ley, Timothy J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN G; RETINOIC ACID RECEPTOR;

ACUTE MYELOBLASTIC LEUKEMIA; ANIMAL CELL; ANIMAL MODEL; ARTICLE; CHROMOSOME TRANSLOCATION 15; CHROMOSOME TRANSLOCATION 17; CONTROLLED STUDY; GENE FUSION; HUMAN; LEUKEMOGENESIS; MOUSE; MYELOPOIESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATOR GENE; TRANSGENIC MOUSE;

EID: 0031033221     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.2.376     Document Type: Article

References (50)

1. Rowley JD, Colomb HM, Dougherty C: 15/17 Translocation, a consistent chromosomal change in acute promyelocytic leukemia. Lancet 1:549, 1977
2. Mitelman F: Catalog of Chromosome Aberations in Cancer (ed 4). New York, NY, Liss, 1991
3. de The H, Chomienne C, Lanotte M, Degos L, Dejean A: The t(15; 17) translocation of acute promyelocytic leukemia fuses the retinoic acid receptor α gene to a novel transcribed locus. Nature 347:558, 1990
4. Kakizuka A, Miller WH Jr, Umesono K, Warrell RP Jr, Frankel SR, Murty VVVS, Dmitrovsky E, Evans RM: Chromosomal translocation t(15; 17) in human acute promyelocytic leukemia fuses RARα with a novel putative transcription factor, PML. Cell 66:663, 1991
5. de The H, Lavau C, Marchio A, Chomienne C, Degos L, Dejean A: The PML-RARα fusion mRNA generated by the t(15; 17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell 66:675, 1991
6. Pandolfi PP, Grignani F, Alcalay M, Mencarelli A, Biondi A, LoCoco F, Grignan F, Pelicci PG: Structure and origin of the acute promyelocytic leukemia myl/RARα cDNA and characterization of its retinoid-binding and transactivation properties. Oncogene 6:1285, 1991
7. Goddard AD, Borrow J, Freemont PS, Solomon E: Characterization of a zinc finger gene disrupted by the t(15; 17) in acute promyelocytic leukemia. Science 254:1371, 1991
8. Kastner P, Perez A, Lutz Y, Rochette-Egly C, Gaub M-P, Durand B, Lanotte M, Berger R, Chambon P: Structure, localization and transcriptional properties of two classes of retinoic acid receptor α fusion proteins in acute promyelocytic leukemia (APL): Structural similarities with a new family of oncoproteins. EMBO J 11:629, 1992
9. Chang K-S, Stass SA, Chu D-T, Deaven LL, Trujillo JM, Freireich EJ: Characterization of a fusion cDNA (RARα/myl) transcribed from the t(15; 17) translocation breakpoint in acute promyelocytic leukemia. Mol Cell Biol 12:800, 1992
10. Alcalay M, Zangrilli D, Fagioli M, Pandolfi PP, Mencarelli A, LoCoco F, Biondi A, Grignani F, Pelicci PG: Expression pattern of the RARα-PML fusion gene in acute promyelocytic leukemia. Proc Natl Acad Sci USA 89:4840, 1992
11. Grignani F, Ferrucci PF, Testa U, Talamo G, Fagioli M, Alcalay M, Mencarelli A, Grignani F, Peschle C, Nicoletti I, Pelicci PG: The acute promyelocytic leukemia-specific PML-RARα fusion protein inhibits differentiation and promotes survival of myeloid precursor cells. Cell 74:423, 1993
12. Rousselot P, Hardas B, Patel A, Guidez F, Gaken J, Castaigne S, Dejean A, de The H, Degos L, Farzaneh F, Chomienne C: The PML-RARα gene product of the t(15; 17) translocation inhibits retinoic acid-induced granulocytic differentiation and mediated transactivation in human myeloid cells. Oncogene 9:545, 1994
13. Collins SJ, Robertson KA, Mueller L: Retinoic acid-induced granulocytic differentiation of HL-60 myeloid leukemia cells is mediated directly through the retinoic acid receptor (RAR-α). Mol Cell Biol 10:2154, 1990
14. Tsai S, Collins SJ: A dominant negative retinoic acid receptor blocks neutrophil differentiation at the promyelocyte stage. Proc Natl Acad Sci USA 90:7153, 1993
15. Onodera M, Kunisada T, Nishikawa S, Sakiyama Y, Matsumoto S, Nishikawa S-I: Overexpression of retinoic acid receptor a suppresses myeloid cell differentiation at the promyelocytic stage. Oncogene 11:1291, 1995
16. Dawson MI, Elstner E, Kizaki M, Chen DL, Pakkala S, Kerner B, Koeffler HP: Myeloid differentiation mediated through retinoic acid receptor/retinoic X receptor (RXR) not RXR/RXR pathway. Blood 84:446, 1994
17. Jansen JH, Mahfoudi A, Rambaud S, Lavau C, Wahli W, Dejean A: Multimeric complexes of the PML-retinoic acid receptor α fusion protein in acute promyelocytic leukemia cells and interference with retinoic and peroxisome-proliferator signaling pathways. Proc Natl Acad Sci USA 92:7401, 1995
18. Perez A, Kastner P, Sethi S, Lutz Y, Reibel C, Chambon P: PML-RAR homodimers: Distinct DNA binding properties and heteromeric interactions with RXR. EMBO J 12:3171, 1993
19. Meng-er H, Yu-chen Y, Shu-rong C, Jia-Xiang L, Lin Z, Long-jun G, Zhen-yi W: Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 72:567, 1988
20. Castaigne S, Chomienne C, Daniel MT, Ballerini P, Berger R, Fenaux P, Degos L: All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results. Blood 76:1704, 1990
21. Chomienne C, Ballerini P, Balitrand N, Daniel MT, Fenaux P, Castaigne S, Degos L: All-trans retinoic acid in acute promyelocytic leukemias. II. In vitro studies: Structure-function relationship. Blood 76:1710, 1990
22. LoCocco F, Avvisati G, Diverio D, Petti MC, Alcalay M, Pandolfi PP, Zangrilli D, Biondi A, Rambaldi A, Moleti ML, Mandelli F, Pelicci PG: Molecular evaluation of response to all-trans-retinoic acid therapy in patients with acute promyelocytic leukemia. Blood 77:1657, 1991
23. Warrell RP Jr, Frankel SR, Miller WH, Scheinberg DA, Itri LM, Hittelman WN, Vyas R, Andreeff M, Tafuri A, Jakubowski A, Gabrilove J, Gordon MS, Dmitrovsky E: Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). N Engl J Med 324:1385, 1991
24. Mu Z-M, Chin K-V, Liu J-H, Lozano G, Chang K-S: PML, a growth suppressor disrupted in acute promyelocytic leukemia. Mol Cell Biol 14:6858, 1994
25. Koken MHM, Linares-Cruz G, Quignon F, Viron A, Chelbi-Alix MK, Sobczak-Thepot J, Juhlin L, Degos L, Calvo F, de The H: The PML growth-suppressor has an altered expression in human oncogenesis. Oncogene 10:1315, 1995
26. Flenghi L, Fagioli M, Tomassoni L, Pileri S, Pacini R, Grignani F, Casini T, Ferrucci PF, Martelli MF, Pelicci PG, Falini B: Cellular localization and tissue distribution of PML proteins as defined by a new monoclonal antibody (PG-M3) directed against the aminoterminal portion of the PML gene product. Preferential expression of PML in post-mitotic cells. Blood 85:1871, 1995
27. Daniel MT, Koken M, Romagne O, Barbey S, Bazarbachi A, Stadler M, Guillemin MC, Degos L, Chomienne C, de The H: PML protein expression in hematopoietic and acute promyelocytic leukemia cells. Blood 82:1858, 1993
28. Dyck JA, Maul GG, Miller WH Jr, Chen JD, Kakizuka A, Evans RM: A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein. Cell 76:333, 1994
29. Weis K, Rambaud S, Lavau C, Jansen J, Carvalho T, Carmo-Fonseca M, Lamond A, Dejean A: Retinoic acid regulates aberrant nuclear localization of PML-RARα in acute promyelocytic leukemia cells. Cell 76:345, 1994
30. Koken MHM, Puvion-Dutilleul F, Guillemin MC, Viron A, Linares-Cruz G, Stuurman N, Jong L de, Szostecki C, Calvo F, Chomienne C, Degos L, Puvion E, de The H: The t(15; 17) translocation alters a nuclear body in a retinoic acid-reversible fashion. EMBO J 13:1073, 1994
31. Chang K-S, Fan Y-H, Andreeff M, Liu J, Mu Z-M: The PML gene encodes a phosphoprotein associated with the nuclear matrix. Blood 85:3646, 1995
32. Turhan AG, Lemoine FM, Debert C, Bonnet ML, Baillou C, Picard F, Macintyre EA, Varet B: Highly purified primitive hematopoietic stem cells are PML-RARα negative and generate nonclonal progenitors in acute promyelocytic leukemia. Blood 85:2154, 1995
33. Hanson RD, Connolly NL, Burnett D, Campbell EJ, Senior RM, Ley TJ: Developmental regulation of the human cathepsin G gene in myelomonocytic cells. J Biol Chem 265:1524, 1990
34. Heusel JW, Scarpati EM, Jenkins NA, Gilbert DJ, Copeland NG, Shapiro SD, Ley TJ: Molecular cloning, chromosomal location, and tissue-specific expression of the murine cathepsin G gene. Blood 81:1614, 1993
35. Grisolano JL, Sclar GM, Ley TJ: Early myeloid cell-specific expression of the human cathepsin G gene in transgenic mice. Proc Natl Acad Sci USA 91:8989, 1994
36. Hanson RD, Ley TJ: Transcriptional activation of the human serine protease gene CSP-B in T-lymphocytes. Mol Cell Biol 10:5655, 1990
37. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156, 1987
38. Ley TJ, Connolly NL, Katamine S, Cheah SC, Senior RM, Robbins KC: Tissue-specific expression and developmental regulation of the human fgr-proto-oncogene. Mol Cell Biol 9:92, 1989
39. Altabef M, Garcia M, Lavau C, Bae S-C, Dejean A, Samarut J: A retrovirus carrying the promyelocyte-retinoic acid receptor PML-RARα fusion gene transforms hematopoietic progenitors in vitro and induces acute leukemia. EMBO J 15:2707, 1996
40. Early E, Moore MAS, Kakizuka A, Nason-Burchenal K, Martin P, Evans RM, Dmitrovsky E: Transgenic expression of PML-RARα impairs myelopoiesis. Proc Natl Acad Sci USA 93:7900, 1996
41. Dziennis S, Van Etten RA, Pahl HL, Morris DL, Rothstein TL, Blosch CM, Perlmutter RM, Tenen DG: The CD11b promoter directs high-level expression of reporter genes in macrophages in transgenic mice. Blood 85:319, 1995
42. Back A, East K, Hickstein D: Leukocyte integrin CD11b promoter directs expression in lymphocytes and granulocytes in transgenic mice. Blood 85:1017, 1995
43. Zhang S-Y, Zhu J, Chen G-Q, Du X-X, Lu L-J, Zhang Z, Zhong H-J, Chen H-R, Wang Z-Y, Berger R, Lanotte M, Waxman S, Chen Z, Chen S-J: Establishment of a human acute promyelocytic leukemia-ascites model in SCID mice. Blood 87:3404, 1996
44. Skalnik DG, Dorfman DM, Perkins AS, Jenkins NA, Copeland NG, Orkin SH: Targeting of transgene expression to monocyte/ macrophages by the gp91-phox promoter and consequent histiocytic malignancies. Proc Natl Acad Sci USA 88:8505, 1991
45. McGuire EA, Rintoul CE, Sclar GM, Korsmeyer SJ: Thymic overexpression of Ttg-1 in transgenic mice results in T-cell acute lymphoblastic leukemia/lymphoma. Mol Cell Biol 12:4186, 1992
46. Rogaia D, Grignani F, Nicolleti I, Pelicci PG: The acute promyelocytic leukemia-specific PML-RARα fusion protein reduces the frequency of commitment to apoptosis upon growth factor deprivation of GM-CSF-dependent myeloid cells. Leukemia 9:1467, 1995
47. Li E, Sucov HM, Lee K-F, Evans RM, Jaenisch R: Normal development and growth of mice carrying a targeted disruption of the α1 retinoic acid receptor gene. Proc Natl Acad Sci USA 90:1590, 1993
48. Lufkin T, Lohnes D, Mark M, Dierich A, Gorry P, Gaub M-P, LeMeur M, Chambon P: High postnatal lethality and testis degeneration in retinoic acid receptor α mutant mice. Proc Natl Acad Sci USA 90:7225, 1993
49. Paggi M, de Fabritiis P, Bonetto F, Amadio L, Santarelli G, Spadea A, Gentile FP, Floridi A, Felsani A: The retinoblastoma gene product in acute myeloid leukemia: A possible involvement in promyelocytic leukemia. Cancer Res 55:4552, 1995
50. Lafage-Pochitaloff M, Alcalay M, Brunel V, Longo L, Sainty D, Simonetti J, Birg F, Pelicci PG: Acute promyelocytic leukemia cases with nonreciprocal PML-RARα or RARα/PML fusion genes. Blood 85:1169, 1995